PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Processa Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.73+0.04 (+2.37%)
Close on Oct 19, 2026
- Market cap
- $4.76M
- P/E (TTM)
- –
- Dividend yield
- –
Processa Pharmaceuticals statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Processa Pharmaceuticals | Industry median |
|---|---|---|
| Market Cap | $4.83M | $166.30M |
| Enterprise Value | $4.64M | $88.19M |
Income (trailing twelve months)
| Measure | Processa Pharmaceuticals | Industry median |
|---|---|---|
| Operating Income | -$13.99M | -$21.40M |
| Net Income | -$13.56M | -$22.46M |
| EBITDA | -$13.99M | -$16.91M |
| EPS (Diluted) | -$10.36 | -$0.83 |
Returns
| Measure | Processa Pharmaceuticals | Industry median |
|---|---|---|
| Return on Assets (ROA) | -655.4% | -40.9% |
Balance sheet
| Measure | Processa Pharmaceuticals | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $196.33K | $61.43M |
| Net Cash (Debt) | $196.33K | $15.35M |
| Net Cash Per Share | $0.07 | $0.66 |
| Equity (Book Value) | -$317.34K | $49.09M |
| Book Value Per Share | -$0.11 | $1.37 |
| Tangible Book Value | -$317.34K | $23.52M |
| Working Capital | -$320.55K | $76.81M |
Financial position
| Measure | Processa Pharmaceuticals | Industry median |
|---|---|---|
| Current Ratio | 0.87 | 3.34 |
| Quick Ratio | 0.08 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Processa Pharmaceuticals | Industry median |
|---|---|---|
| Operating Cash Flow | -$11.39M | -$12.35M |
Efficiency
| Measure | Processa Pharmaceuticals | Industry median |
|---|---|---|
| Profits Per Employee | -$1.13M | -$703.34K |
| Employee Count | 12 | 74 |
Dividends and yields
| Measure | Processa Pharmaceuticals | Industry median |
|---|---|---|
| Earnings Yield | -280.7% | -23.3% |
Shares
| Measure | Processa Pharmaceuticals | Industry median |
|---|---|---|
| Shares Outstanding | 2,793,390 | 58,127,000 |
| Shares Change (YoY) | 969.3% | 10.9% |
| Shares Change (QoQ) | 4.32% | 0.54% |
| Shares Held by Institutions | 9.15% | 59.4% |
Scores
| Measure | Processa Pharmaceuticals | Industry median |
|---|---|---|
| Altman Z-Score | -93.95 | -0.22 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Processa Pharmaceuticals's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.